Integration of breast MRI in clinical trials

Journal of Magnetic Resonance Imaging

Volumn 13, Issue 6, 2001, Pages 830-836

  Harms, Steven E ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Breast diagnosis; Breast neoplasms; Breast neoplasms therapy; Clinical trials; MRI

Indexed keywords

BREAST; CANCER DIAGNOSIS; CLINICAL PRACTICE; DIAGNOSTIC IMAGING; HEALTH CARE ORGANIZATION; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PRIORITY JOURNAL; REVIEW;

BREAST; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CLINICAL TRIALS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE OF TESTS;

EID: 0035019578     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1118     Document Type: Review

References (25)

1. Hortobagyi GN, Buzdar AU. Locally advanced breast cancer. In: Bonadonna G, Hortobagyi GN, Gianni AM, editors. Textbook of breast cancer: a clinical guide to therapy. London: Dunniz; 1997. p 153-168.
2. Chittoor SR, Swain S. Locally advanced breast cancer: role of medical oncology. In: Bland KI, Copeland EM III, editors. The breast: comprehensive management of benign and malignant diseases. Philadelphia: WB Saunders; 1998. p 1260-1298.
3. Abraham DC, Jones RC, Jones SE, Cheek JH, Peters GN, Knox SM, Grant MD, Hampe DW, Savino DA, Harms SE. Evaluation of noadjuvant chemotherapeutic response in locally advanced breast cancer by magnetic resonance imaging. Cancer 1996;78:91-100.
4. Gilles R, Guinebretiere JM, Toussaint C, Spielman M, Rietjens M, Petit JY, Contesso G, Maselot J, Vanel D. Locally advanced breast cancer: contrast-enhanced subtraction MR imaging of response to preoperative chemotherapy. Radiology 1994;191:633-638.
5. Schnall MD, Orel SG, McDermott J, Englander SA. Breast MRI on patients taking tamoxifen. Proc Intl Soc Magn Reson Med 1999;7: 360.
6. Lagios MD, Westdahy PR, Rose MR. The concept and implications of multicentricity in breast carcinoma. In: Sommers SG, Rosen PP, editors. Pathology Annual. New York: Appleton-Century-Crofts; 1981. p 83-102.
7. Holland R, Veling SHJ, Mravunac M, Hendricks JHCL. Histologic multifocality of Tis, T1-2 breast carcinomas: implication for clinical trials of breast-conserving surgery. Cancer 1985;56:979-990.
8. Schwartz GF, Patchesfsky AS, Feig SA, et al. Multicentricity of nonpalpable breast cancer. Cancer 1980;45:2913-2916.
9. Rosen PP, Braun DW Jr, Kinne DE. The clinical significance of preinvasive breast carcinoma. Cancer 1980;46:919-925.
10. Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989;320:822-828.
11. Harms SE, Flamig DP, Hesley KL, et al. Breast MRI: rotating delivery of excitation off-resonance: clinical experience with pathologic correlations. Radiology 1993;187:493-501.
12. Rodenko GN, Harms SE, Farrell RS, Pruneda JM, Evans WP, Copit DS, Krakos PA, Flamig DP. MR imaging in the management before surgery of lobular carcinoma of the breast: comparison with pathology. Am J Roentgenol 1996;167:1415.
13. Harms SE, Flamig DP, Evans WP, Brown S, Harries SA. MR imaging of the breast: current status and future potential. Am J Roentgenol 1994;163:1039-1047.
14. Soderstrom CE, Harms SE, Farrell RS, Pruneda JM, Evans WP, Copit DS, Krakos PA, Flamig DP. MRI assessment of residual breast cancer post-lumpectomy. Am J Roentgenol 1997;168:485-488.
15. Harms SE, Flamig DP. Staging of breast cancer with magnetic resonance. MRI Clin North Am 1994;2:40.
16. Harms SE. Integration of breast magnetic resonance imaging with breast cancer treatment. Top Magn Reson Imaging 1998;9: 79-91.
17. Harms SE. Breast magnetic resonance imaging. Semin Ultrasound CT MRI 1998;19:104-120.
18. Lagios MD, Margolin FR, Westdahl PR, et al. Mammographically detected duct carcinoma in situ: frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989;63:618-624.
19. Silverstein MJ, Lagios M, Craig P, et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer 1996;77:2267-2274.
20. Silverstein MJ. Ductal carcinoma in situ of the breast. Baltimore: Williams and Wilkins, 1997. 665 p.
21. Soderstrom CE, Harms SE, Copit DS, et al. 3D RODEO breast MRI of lesions containing ductal carcinoma In situ. Radiology 1996;201: 427-432.
22. Veronesi U, Cascinelli N, Greco M, et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 1985;202:702-707.
23. Goldhirsch A, Wood WC, Senn H-J, et al. Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 1995;87:1441-1445.
24. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
25. Harms SE, Hinton T, Manning L, Korourian S. New MRI contrast agent for labeling of tumor-associated macrophages that stimulate tumor angiogenesis. Proc Intl Soc Mag Reson Med 2000;8:616.